A potential game-changer in the tuberculosis epidemic was how the tuberculosis community viewed rapid molecular tests for tuberculosis and tuberculosis drug resistance. This was 12 years ago, with the ...

In 2022, more than 78,000 new cases of tuberculosis (TB) were reported in Brazil, with an incidence of 36.3 cases per 100,000 inhabitants. According to researchers from the Regional Prospective ...

A 9-month regimen of isoniazid can prevent active tuberculosis in persons with latent tuberculosis infection. However, the regimen has been associated with poor adherence rates and with toxic effects.

First-line medication for TB is a quadruple therapy regimen of rifampicin, isoniazid, pyrazinamide and ethambutol for two months, followed by a four month continuation phase of rifampicin and ...

Rifampicin was given along with standard doses of other first-line anti-TB drugs (isoniazid, ethambutol and pyrazinamide) for the first two months. Patients were followed-up monthly for the first 12 ...

(RTTNews) - Johnson & Johnson (JNJ), a global health care company, has received full approval from the US FDA and the European Commission for Sirturo (bedaquiline), a treatment specifically designed ...

A new six-month treatment reg­i­men to treat druf-resistant tuberculosis marks a potentially transformative shift.